Lisette E. E. van der Houwen, Anneke M. F

Slides:

Advertisements

Similar presentations

Essure hysteroscopic tubal occlusion device for the treatment of hydrosalpinx prior to in vitro fertilization-embryo transfer in patients with a contraindication.

Advertisements

Development of guideline-based quality indicators for recurrent miscarriage E. van den Boogaard, M. Goddijn, N.J. Leschot, F. van der Veen, J.A.M. Kremer,

Miscarriage risk for IVF pregnancies in poor responders to ovarian hyperstimulation Maaike L Haadsma, Henk Groen, Thea M Mooij, Curt W Burger, Frank JM.

Impact of positive hepatitis B surface antigen on the outcome of IVF treatment Vivian Chi Yan Lee, Ernest Hung Yu Ng, William Shu Biu Yeung, Pak Chung.

Lisette E. E. van der Houwen, Anneke M. F

L. M. Moolenaar, M. Connolly, B. Huisman, M. J. Postma, P. G. A

Adverse pregnancy and neo-natal outcomes after assisted reproductive treatment in patients with pelvic endometriosis: a case–control study Marianne Jacques,

Effect of androgen supplementation or modulation on ovarian stimulation outcome in poor responders: a meta-analysis Sesh Kamal Sunkara, Jyotsna Pundir,

Blood-borne angiogenic factors and sustained multiple implantation: a comparison of singleton and twin pregnancies Els Groeneveld, Marieke J. Lambers,

Efficacy and safety of IVF/ICSI in patients with severe endometriosis after long-term pituitary down-regulation Lisette E.E. van der Houwen, Velja Mijatovic,

Diet and endometriosis risk: A literature review

Miscarriage risk for IVF pregnancies in poor responders to ovarian hyperstimulation Maaike L Haadsma, Henk Groen, Thea M Mooij, Curt W Burger, Frank JM.

Risk of pelvic inflammatory disease after intrauterine insemination: a systematic review Roberto Matorras, Kristian Rubio, María Iglesias, Itziar Vara,

Cost-effectiveness of assisted conception for male subfertility

FMR1 gene CGG repeat variation within the normal range is not predictive of ovarian response in IVF cycles Scott J. Morin, Ashley W. Tiegs, Jason M.

Complete surgical removal of minimal and mild endometriosis improves outcome of subsequent IVF/ICSI treatment H.K. Opøien, P. Fedorcsak, T. Åbyholm,

Diagnostic accuracy of hysterosalpingo-foam-sonography to confirm tubal occlusion after Essure® placement as treatment for hydrosalpinges Kim Dreyer,

Long-term follow up of couples initially randomized between immobilization and immediate mobilization subsequent to IUI I. Scholten, I.M. Custers, L.M.

IVF with planned single-embryo transfer versus IUI with ovarian stimulation in couples with unexplained subfertility: an economic analysis Minouche M.E.

Bruce S. Shapiro, Said T. Daneshmand, Humberto Restrepo, Forest C

A. Osman, J. Pundir, M. Elsherbini, S. Dave, T. El-Toukhy, Y. Khalaf

Ovarian stimulation and intrauterine insemination in women aged 40years or more Amir Wiser, Einat Shalom-Paz, Shauna Leigh Reinblatt, Weon-Young Son,

No association between endogenous LH and pregnancy in a GnRH antagonist protocol: part II, recombinant FSH George Griesinger, Daniel B. Shapiro, Efstratios.

Management of ovarian stimulation for IVF: narrative review of evidence provided for World Health Organization guidance Cindy Farquhar, Jane Marjoribanks,

Anti-Müllerian hormone for the assessment of ovarian response in GnRH-antagonist- treated oocyte donors Nikolaos P. Polyzos, Dominic Stoop, Christophe.

In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation

L. L. van Loendersloot, M. van Wely, S. Repping, F. van der Veen, P. M

High serum oestradiol concentrations in IVF cycles increase the risk of pregnancy complications related to abnormal placentation Jacob Farhi, Avi Ben.

Publication productivity in IVF in Europe, 1990–2006

Establishment and validation of a score to predict ovarian response to stimulation in IVF Clelia Chalumeau, Jessika Moreau, Nicolas Gatimel, Clementine.

Anti-Müllerian hormone as a predictor of pregnancy following IVF

A multi-centre phase 3 study comparing efficacy and safety of Bemfola® versus Gonal- f® in women undergoing ovarian stimulation for IVF M. Rettenbacher,

Couples with unexplained subfertility and unfavorable prognosis: a randomized pilot trial comparing the effectiveness of in vitro fertilization with elective.

Why are reproductive cancers more common in nulliparous women?

Perinatal outcomes after stimulated versus natural cycle IVF: a systematic review and meta-analysis Mohan Shashikant Kamath, Richard Kirubakaran, Mariano.

Semen cryopreservation and usage rate for assisted reproductive technology in 898 men with cancer Iris Muller, Ralph J.A. Oude Ophuis, Frank J.M. Broekmans,

Moniek van der Zanden, Annemiek W. Nap Reproductive BioMedicine Online

What’s on the mind of IVF consumers?

Non-invasive viability assessment of day-4 frozen–thawed human embryos using near infrared spectroscopy Carlijn G. Vergouw, Lucy L. Botros, Kevin Judge,

Sarah McCredie, William Ledger, Christos A. Venetis

Effect of N-acetyl-cysteine after ovarian drilling in clomiphene citrate-resistant PCOS women: a pilot study A. Nasr Reproductive BioMedicine Online

Cumulative live-birth delivery after IVF/ICSI since the progressive introduction of single- embryo transfer D. De Neubourg, C. Daels, M. Elseviers, K.

Effect of energy expenditure and physical activity on the outcomes of assisted reproduction treatment Mert Kucuk, Fadime Doymaz, Bulent Urman Reproductive.

Lisette E. E. van der Houwen, Anneke M. F

Jyotsna Pundir, Sesh Kamal Sunkara, Tarek El-Toukhy, Yacoub Khalaf

Myotonic dystrophy type 1 and PGD: ovarian stimulation response and correlation analysis between ovarian reserve and genotype C. Dechanet, C. Castelli,

Male age negatively influences clinical pregnancy rate in women younger than 40 years undergoing donor insemination cycles Su-Ann Koh, Katherine Sanders,

Impact of positive hepatitis B surface antigen on the outcome of IVF treatment Vivian Chi Yan Lee, Ernest Hung Yu Ng, William Shu Biu Yeung, Pak Chung.

A retrospective analysis of ovarian stimulation with letrozole in women undergoing artificial insemination by donor X.J. Sun, L. Jiang, L.C. Ji, R. Nie,

Impact of vitamin D levels on ovarian reserve and ovarian response to ovarian stimulation in oocyte donors Alberta Maria Fabris, Maria Cruz, Carlos Iglesias,

Effect of the woman’s age on discontinuation of IVF treatment

Intra-cycle variation of the uterine cavity indentation assessed with three-dimensional ultrasound in natural and stimulated cycles Sotirios H. Saravelos,

LH concentrations do not correlate with pregnancy in rFSH/GnRH antagonist cycles Kevin Doody, Paul Devroey, Keith Gordon, Han Witjes, Bernadette Mannaerts

Shared motherhood IVF: high delivery rates in a large study of treatments for lesbian couples using partner-donated eggs D. Bodri, S. Nair, A. Gill,

Mohamed A. Aboulghar, Heba Marie, Yahia M. Amin, Mona M

Improving the Reporting of Clinical Trials of Infertility Treatments (IMPRINT): modifying the CONSORT statement Fertility and Sterility Volume 102,

Adverse pregnancy and neo-natal outcomes after assisted reproductive treatment in patients with pelvic endometriosis: a case–control study Marianne Jacques,

S. Seshadri, S.K. Sunkara, Y. Khalaf, T. El-Toukhy, H. Hamoda

Stephen C. Collins, Esther Chan Reproductive BioMedicine Online

GnRH antagonist pre-treatment: one centre's experience for IVF–ICSI cycle scheduling Veronique Viardot-Foucault, Sadhana Nadarajah, Weng Kit Lye, Heng.

Ovarian stimulation and endometriosis progression or recurrence: a systematic review Edgardo Somigliana, Paola Viganò, Laura Benaglia, Andrea Busnelli,

Pietro Gambadauro, Ramesan Navaratnarajah

Genome-wide analysis shows no genomic predictors of ovarian response to stimulation by exogenous FSH for IVF Jeroen van Disseldorp, Lude Franke, Rene.

The Alpha Consensus Meeting on the professional status of the clinical embryologist: proceedings of an expert meeting Reproductive BioMedicine Online

Ovarian reserve screening before contraception?

Thomas M. D’Hooghe, M. D. , Ph. D. , Bénédicte Denys, M. D

Yakoub Khalaf, Susan Bewley, Peter Braude

M. Franz, J. Ott, A. Watrelot, L. Küssel, H. Husslein

Cost-effectiveness of treatment strategies in women with PCOS who do not conceive after six cycles of clomiphene citrate Lobke M. Moolenaar, Marleen.

Use of progestins to inhibit spontaneous ovulation during ovarian stimulation: the beginning of a new era? Antonio La Marca, Martina Capuzzo Reproductive.

Presentation transcript:

Efficacy and safety of intrauterine insemination in patients with moderate-to-severe endometriosis Lisette E.E. van der Houwen, Anneke M.F. Schreurs, Roel Schats, Martijn W. Heymans, Cornelis B. Lambalk, Peter G.A. Hompes, Velja Mijatovic Reproductive BioMedicine Online Volume 28, Issue 5, Pages 590-598 (May 2014) DOI: 10.1016/j.rbmo.2014.01.005 Copyright © 2014 Reproductive Healthcare Ltd. Terms and Conditions

Figure 1 Flowchart of patients. Reproductive BioMedicine Online 2014 28, 590-598DOI: (10.1016/j.rbmo.2014.01.005) Copyright © 2014 Reproductive Healthcare Ltd. Terms and Conditions

Figure 2 Kaplan–Meier curves of cumulative ongoing pregnancy rates according to IUI treatment cycle for the total population (A), IUI with natural/ovarian stimulation versus IUI with ovarian stimulation (B, P=0.016) and with/without GnRH-agonist treatment (C). Reproductive BioMedicine Online 2014 28, 590-598DOI: (10.1016/j.rbmo.2014.01.005) Copyright © 2014 Reproductive Healthcare Ltd. Terms and Conditions

Figure 3 Kaplan–Meier curves of cumulative ongoing pregnancy rates according to time after start of treatment for IUI with natural/ovarian stimulation versus IUI with ovarian stimulation for only IUI-conceived ongoing pregnancies (A, P=0.014) and including naturally and IVF-conceived ongoing pregnancies (B, P=0.008). Reproductive BioMedicine Online 2014 28, 590-598DOI: (10.1016/j.rbmo.2014.01.005) Copyright © 2014 Reproductive Healthcare Ltd. Terms and Conditions

Figure 4 Kaplan–Meier curves of cumulative endometriosis recurrence rate (CERR) per month after start of IUI treatment for the total population (A), IUI with natural/ovarian stimulation versus IUI with ovarian stimulation (B, P=0.021) and with/without GnRH-agonist treatment (C, P=0.016). Reproductive BioMedicine Online 2014 28, 590-598DOI: (10.1016/j.rbmo.2014.01.005) Copyright © 2014 Reproductive Healthcare Ltd. Terms and Conditions